Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin with ECP for steroid-refractory acute graft-versus-host disease
MOH_2020-07-09_009128Phase 2Not yet recruiting
- Sponsor
- משה ישורון
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sitagliptin in Acute Graft-Versus-Host Disease (aGvHD), sponsored by משה ישורון. Planned start Jul 2020; status: not yet recruiting.
02
Drugs
sitagliptin
03
Conditions
Acute Graft-Versus-Host Disease (aGvHD)
Beyond the preview
Go deeper on MOH_2020-07-09_009128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-07-09_009128.